Wenliang Ma
- Co-authors
- Dongmei LiYanwen LuLei YangWeidong GanNing LiuYi ChenWenxiong LiWeijian Li
- Topics
- Renal cell carcinoma treatment (10 papers)Renal and related cancers (9 papers)Bladder and Urothelial Cancer Treatments (6 papers)
- Partner nations
- ChinaMalaysiaUnited States
In The Last Decade
Wenliang Ma
28 papers receiving 243 citations
Peers
Comparison fields: 5 of 50
- Molecular Biology 165
- Cancer Research 91
- Pulmonary and Respiratory Medicine 83
- Epidemiology 31
- Surgery 24
Countries citing papers authored by Wenliang Ma
This map shows the geographic impact of Wenliang Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenliang Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenliang Ma more than expected).
Fields of papers citing papers by Wenliang Ma
This network shows the impact of papers produced by Wenliang Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenliang Ma. The network helps show where Wenliang Ma may publish in the future.
Co-authorship network of co-authors of Wenliang Ma
This figure shows the co-authorship network connecting the top 25 collaborators of Wenliang Ma. A scholar is included among the top collaborators of Wenliang Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wenliang Ma. Wenliang Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 0 | |
| 3 | 0 | |
| 4 | 9 | |
| 5 | 1 | |
| 6 | 3 | |
| 7 | 4 | |
| 8 | 7 | |
| 9 | 16 | |
| 10 | 44 | |
| 11 | 4 | |
| 12 | 12 | |
| 13 | 12 | |
| 14 | 1 | |
| 15 | 6 | |
| 16 | 11 | |
| 17 | 5 | |
| 18 | 23 | |
| 19 | 3 | |
| 20 | 20 |
About Wenliang Ma
Wenliang Ma is a scholar working on Cancer Research, Critical Care and Intensive Care Medicine and Pulmonary and Respiratory Medicine, having authored 31 papers that have together received 243 indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (10 papers), Renal and related cancers (9 papers) and Bladder and Urothelial Cancer Treatments (6 papers). The work is most often cited by research in Cancer Research (91 citations), Pulmonary and Respiratory Medicine (83 citations) and Molecular Biology (165 citations). Wenliang Ma has collaborated with scholars based in China, Malaysia and United States. Frequent co-authors include Dongmei Li, Yanwen Lu, Lei Yang, Weidong Gan, Ning Liu, Weidong Gan, Yi Chen, Wenxiong Li, Weijian Li and Yue Zheng. Their work appears in journals such as Scientific Reports, Molecular Cancer and Cancer Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.